Trait Information | |
Identifier | MONDO_0002254 |
Description | A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition. [NCIT: C28193] | Trait category |
Other disease
|
Synonyms |
9 synonyms
|
Mapped terms |
6 mapped terms
|
Child trait(s) | 8 child traits |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000198 (G-PROB_PsA) |
PGP000081 | Knevel R et al. Sci Transl Med (2020) |
Psoriatic arthritis | psoriatic arthritis | 31 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000198/ScoringFiles/PGS000198.txt.gz |
PGS000342 (wGRS_PsA) |
PGP000111 | Smith MP et al. J Psoriasis Psoriatic Arthritis (2020) |
Psoriatic arthritis | psoriatic arthritis | 11 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000342/ScoringFiles/PGS000342.txt.gz |
PGS000343 (wGRS_PsA_HLA) |
PGP000111 | Smith MP et al. J Psoriasis Psoriatic Arthritis (2020) |
Psoriatic arthritis | psoriatic arthritis | 5 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000343/ScoringFiles/PGS000343.txt.gz |
PGS000737 (PRS_BrS) |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Brugada syndrome | Brugada syndrome | 3 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000737/ScoringFiles/PGS000737.txt.gz |
PGS000922 (GBE_HC170) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Sarcoidosis | sarcoidosis | 12 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000922/ScoringFiles/PGS000922.txt.gz |
PGS000923 (GBE_HC639) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Sarcoidosis (time-to-event) | sarcoidosis | 22 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000923/ScoringFiles/PGS000923.txt.gz |
PGS001051 (GBE_HC96) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Polymyalgia rheumatica | polymyalgia rheumatica | 69 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001051/ScoringFiles/PGS001051.txt.gz |
PGS001287 (GBE_HC91) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Psoriatic arthropathy | psoriatic arthritis | 36 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001287/ScoringFiles/PGS001287.txt.gz |
PGS001308 (GBE_HC321) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Sjogren's syndrome/sicca syndrome | Sjogren syndrome | 7 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001308/ScoringFiles/PGS001308.txt.gz |
PGS001779 (BRSprs) |
PGP000260 | Barc J et al. Nat Genet (2022) |
Brugada syndrome | Brugada syndrome | 21 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001779/ScoringFiles/PGS001779.txt.gz |
PGS001872 (portability-PLR_697) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Sarcoidosis | skin sarcoidosis | 79 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001872/ScoringFiles/PGS001872.txt.gz |
PGS001878 (portability-PLR_717) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Polymyalgia rheumatica | polymyalgia rheumatica | 142 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001878/ScoringFiles/PGS001878.txt.gz |
PGS002084 (portability-ldpred2_697) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Sarcoidosis | skin sarcoidosis | 403,417 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002084/ScoringFiles/PGS002084.txt.gz |
PGS002091 (portability-ldpred2_717) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Polymyalgia rheumatica | polymyalgia rheumatica | 129,938 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002091/ScoringFiles/PGS002091.txt.gz |
PGS003354 (SSNS-GRS) |
PGP000407 | Downie ML et al. Pediatr Nephrol (2022) |
Childhood steroid-sensitive nephrotic syndrome | nephrotic syndrome | 5 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003354/ScoringFiles/PGS003354.txt.gz |
PGS003479 (LDPred2_SleepApnea) |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Obstructive sleep apnea | obstructive sleep apnea | 836,839 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003479/ScoringFiles/PGS003479.txt.gz |
PGS003857 (GRS18_BMIunadj) |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Obstructive sleep apnea | obstructive sleep apnea | 18 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003857/ScoringFiles/PGS003857.txt.gz |
PGS003858 (GRS6_BMIadj) |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Obstructive sleep apnea (BMI adjusted) | obstructive sleep apnea | 6 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003858/ScoringFiles/PGS003858.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM000581 | PGS000198 (G-PROB_PsA) |
PSS000313| European Ancestry| 243 individuals |
PGP000081 | Knevel R et al. Sci Transl Med (2020) |
Reported Trait: Psoriatic arthritis diagnosis in patient with arthritis | — | AUROC: 0.62 [0.48, 0.8] | — | — | (Setting III: Selecting patients presenting with inflammatory arthritis at their first visit) |
PPM000575 | PGS000198 (G-PROB_PsA) |
PSS000312| European Ancestry| 245 individuals |
PGP000081 | Knevel R et al. Sci Transl Med (2020) |
Reported Trait: Psoriatic arthritis diagnosis in patient with arthritis | — | AUROC: 0.71 [0.63, 0.82] | — | — | (Setting II: Assigning patient diagnoses based on medical records) |
PPM000569 | PGS000198 (G-PROB_PsA) |
PSS000321| Multi-ancestry (including European)| 1,211 individuals |
PGP000081 | Knevel R et al. Sci Transl Med (2020) |
Reported Trait: Psoriatic arthritis diagnosis in patient with arthritis | — | AUROC: 0.61 [0.52, 0.69] | — | — | (Setting I: Assigning patient diagnoses based on billing codes) |
PPM000971 | PGS000342 (wGRS_PsA) |
PSS000490| Ancestry Not Reported| 543 individuals |
PGP000111 | Smith MP et al. J Psoriasis Psoriatic Arthritis (2020) |
Reported Trait: Psoriatic arthritis | — | AUROC: 0.562 [0.506, 0.618] | — | — | — |
PPM000972 | PGS000343 (wGRS_PsA_HLA) |
PSS000490| Ancestry Not Reported| 543 individuals |
PGP000111 | Smith MP et al. J Psoriasis Psoriatic Arthritis (2020) |
Reported Trait: Psoriatic arthritis | — | AUROC: 0.569 [0.513, 0.625] | — | — | — |
PPM001757 | PGS000737 (PRS_BrS) |
PSS000905| European Ancestry| 1,185 individuals |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Reported Trait: Ajmaline-induced Type I Brugada syndrome electrocardiogram | OR: 1.174 [1.138, 1.21] | — | — | — | — |
PPM001758 | PGS000737 (PRS_BrS) |
PSS000905| European Ancestry| 1,185 individuals |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Reported Trait: Ajmaline-induced Type I Brugada syndrome electrocardiogram | — | C-index: 0.68 [0.65, 0.71] | correlation coefficient (r): -0.14 | — | — |
PPM007440 | PGS000922 (GBE_HC170) |
PSS004322| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sarcoidosis | — | AUROC: 0.70759 [0.63998, 0.7752] | PGS R2 (no covariates): 0.02057 R²: 0.05219 Incremental AUROC (full-covars): 0.03111 PGS AUROC (no covariates): 0.64298 [0.57429, 0.71167] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007441 | PGS000922 (GBE_HC170) |
PSS004323| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sarcoidosis | — | AUROC: 0.67662 [0.6145, 0.73874] | R²: 0.03062 Incremental AUROC (full-covars): 0.02209 PGS R2 (no covariates): 0.00799 PGS AUROC (no covariates): 0.60582 [0.54774, 0.66391] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007442 | PGS000922 (GBE_HC170) |
PSS004324| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sarcoidosis | — | AUROC: 0.66108 [0.58927, 0.7329] | R²: 0.03112 Incremental AUROC (full-covars): 0.00713 PGS R2 (no covariates): 0.00089 PGS AUROC (no covariates): 0.52621 [0.44905, 0.60338] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007443 | PGS000922 (GBE_HC170) |
PSS004325| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sarcoidosis | — | AUROC: 0.6486 [0.60932, 0.68789] | R²: 0.01916 Incremental AUROC (full-covars): 0.09187 PGS R2 (no covariates): 0.01741 PGS AUROC (no covariates): 0.64282 [0.60353, 0.68211] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007444 | PGS000923 (GBE_HC639) |
PSS004551| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE sarcoidosis | — | AUROC: 0.70171 [0.64012, 0.7633] | R²: 0.05018 Incremental AUROC (full-covars): 0.03514 PGS R2 (no covariates): 0.02657 PGS AUROC (no covariates): 0.66456 [0.60597, 0.72315] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007445 | PGS000923 (GBE_HC639) |
PSS004552| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE sarcoidosis | — | AUROC: 0.67371 [0.61511, 0.7323] | R²: 0.02923 Incremental AUROC (full-covars): 0.00926 PGS R2 (no covariates): 0.00429 PGS AUROC (no covariates): 0.58898 [0.53125, 0.64671] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007446 | PGS000923 (GBE_HC639) |
PSS004553| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE sarcoidosis | — | AUROC: 0.67148 [0.61146, 0.73151] | R²: 0.0372 Incremental AUROC (full-covars): 0.00677 PGS R2 (no covariates): 0.00103 PGS AUROC (no covariates): 0.52237 [0.45814, 0.58661] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007447 | PGS000923 (GBE_HC639) |
PSS004554| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE sarcoidosis | — | AUROC: 0.65455 [0.6217, 0.6874] | R²: 0.02088 Incremental AUROC (full-covars): 0.09004 PGS R2 (no covariates): 0.018 PGS AUROC (no covariates): 0.64561 [0.61168, 0.67954] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008013 | PGS001051 (GBE_HC96) |
PSS004751| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Polymyalgia rheumatica | — | AUROC: 0.84007 [0.73377, 0.94637] | R²: 0.10995 Incremental AUROC (full-covars): 0.00396 PGS R2 (no covariates): 0.0041 PGS AUROC (no covariates): 0.59347 [0.45814, 0.7288] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008014 | PGS001051 (GBE_HC96) |
PSS004752| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Polymyalgia rheumatica | — | AUROC: 0.94435 [0.88977, 0.99892] | R²: 0.24363 Incremental AUROC (full-covars): 0.00372 PGS R2 (no covariates): 0.00287 PGS AUROC (no covariates): 0.45385 [0.09439, 0.81331] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008015 | PGS001051 (GBE_HC96) |
PSS004753| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Polymyalgia rheumatica | — | AUROC: 0.82077 [0.78717, 0.85438] | R²: 0.12384 Incremental AUROC (full-covars): 0.0077 PGS R2 (no covariates): 0.01385 PGS AUROC (no covariates): 0.60167 [0.54507, 0.65826] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008016 | PGS001051 (GBE_HC96) |
PSS004754| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Polymyalgia rheumatica | — | AUROC: 0.73708 [0.62459, 0.84956] | R²: 0.05254 Incremental AUROC (full-covars): 0.00266 PGS R2 (no covariates): 0.00471 PGS AUROC (no covariates): 0.54813 [0.38601, 0.71025] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008017 | PGS001051 (GBE_HC96) |
PSS004755| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Polymyalgia rheumatica | — | AUROC: 0.76042 [0.73986, 0.78098] | R²: 0.07774 Incremental AUROC (full-covars): 0.0165 PGS R2 (no covariates): 0.01265 PGS AUROC (no covariates): 0.61026 [0.58102, 0.6395] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008933 | PGS001287 (GBE_HC91) |
PSS004706| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriatic arthropathy | — | AUROC: 0.98006 [0.94602, 1.0] | Incremental AUROC (full-covars): 0.00516 R²: 0.29301 PGS R2 (no covariates): 0.01017 PGS AUROC (no covariates): 0.72132 [0.63231, 0.81034] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008934 | PGS001287 (GBE_HC91) |
PSS004707| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriatic arthropathy | — | AUROC: 0.99354 [0.98059, 1.0] | R²: 0.5357 Incremental AUROC (full-covars): -0.00088 PGS R2 (no covariates): 0.00227 PGS AUROC (no covariates): 0.47826 [0.0, 0.96911] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008935 | PGS001287 (GBE_HC91) |
PSS004708| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriatic arthropathy | — | AUROC: 0.72814 [0.67154, 0.78475] | R²: 0.05154 Incremental AUROC (full-covars): 0.08346 PGS R2 (no covariates): 0.0335 PGS AUROC (no covariates): 0.67648 [0.61155, 0.7414] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008936 | PGS001287 (GBE_HC91) |
PSS004709| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriatic arthropathy | — | AUROC: 0.71827 [0.61363, 0.82292] | R²: 0.04395 Incremental AUROC (full-covars): 0.00838 PGS R2 (no covariates): 0.00229 PGS AUROC (no covariates): 0.56943 [0.44876, 0.69011] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008937 | PGS001287 (GBE_HC91) |
PSS004710| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Psoriatic arthropathy | — | AUROC: 0.6376 [0.60073, 0.67447] | R²: 0.02161 Incremental AUROC (full-covars): 0.0945 PGS R2 (no covariates): 0.02111 PGS AUROC (no covariates): 0.63567 [0.598, 0.67334] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009034 | PGS001308 (GBE_HC321) |
PSS004437| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sjogren's syndrome/sicca syndrome | — | AUROC: 0.79846 [0.71474, 0.88218] | R²: 0.07345 Incremental AUROC (full-covars): 0.0079 PGS R2 (no covariates): 0.01471 PGS AUROC (no covariates): 0.59027 [0.45551, 0.72504] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009035 | PGS001308 (GBE_HC321) |
PSS004438| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sjogren's syndrome/sicca syndrome | — | AUROC: 0.75824 [0.55089, 0.96558] | R²: 0.05686 Incremental AUROC (full-covars): 0.00691 PGS R2 (no covariates): 0.0091 PGS AUROC (no covariates): 0.69794 [0.63241, 0.76347] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009036 | PGS001308 (GBE_HC321) |
PSS004439| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sjogren's syndrome/sicca syndrome | — | AUROC: 0.77174 [0.71988, 0.82361] | R²: 0.07435 Incremental AUROC (full-covars): 0.01461 PGS R2 (no covariates): 0.01453 PGS AUROC (no covariates): 0.65693 [0.58901, 0.72485] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009037 | PGS001308 (GBE_HC321) |
PSS004440| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sjogren's syndrome/sicca syndrome | — | AUROC: 0.8014 [0.74455, 0.85826] | R²: 0.08893 Incremental AUROC (full-covars): 0.00953 PGS R2 (no covariates): 0.03189 PGS AUROC (no covariates): 0.61034 [0.48809, 0.73259] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009038 | PGS001308 (GBE_HC321) |
PSS004441| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Sjogren's syndrome/sicca syndrome | — | AUROC: 0.73313 [0.69647, 0.76978] | R²: 0.04771 Incremental AUROC (full-covars): 0.01551 PGS R2 (no covariates): 0.01074 PGS AUROC (no covariates): 0.60303 [0.55292, 0.65315] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009271 | PGS001779 (BRSprs) |
PSS007680| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Supraventricular tachycardia | OR: 0.92 [0.89, 0.96] | — | p-value: 4e-05 | — | — |
PPM009270 | PGS001779 (BRSprs) |
PSS007675| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Conduction system disorder orbradyarrhythmia | OR: 1.06 [1.03, 1.08] | — | p-value: 4.63e-06 | — | — |
PPM009272 | PGS001779 (BRSprs) |
PSS007676| European Ancestry| 11,942 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: PQ interval | β: 2.69866 | — | p-value: 1.90e-45 | — | — |
PPM009273 | PGS001779 (BRSprs) |
PSS007677| European Ancestry| 11,566 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: P wave duration | β: 0.7576 | — | p-value: 5.32e-09 | — | — |
PPM009274 | PGS001779 (BRSprs) |
PSS007678| European Ancestry| 11,877 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: QRS complex duration | β: 1.23043 | — | p-value: 4.21e-55 | — | — |
PPM009268 | PGS001779 (BRSprs) |
PSS007671| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Atrial fibrillation or flutter | OR: 0.94 [0.92, 0.95] | — | p-value: 6.22e-13 | — | — |
PPM009269 | PGS001779 (BRSprs) |
PSS007672| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Atrioventricular conduction disorder | OR: 1.16 [1.1, 1.21] | — | p-value: 1.47e-09 | — | — |
PPM009275 | PGS001779 (BRSprs) |
PSS007679| European Ancestry| 11,893 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: QT interval | β: -1.56242 | — | p-value: 4.75e-16 | — | — |
PPM009266 | PGS001779 (BRSprs) |
PSS007673| European Ancestry| 2,469 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: SCN5A Mutation in Burgada syndrome cases | β: -0.45 | — | p-value: 2.10e-17 | — | — |
PPM009267 | PGS001779 (BRSprs) |
PSS007674| European Ancestry| 2,820 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Brugada baseline or drug-induced type 1 ECG in Burgada syndrome cases | β: 0.18 | — | p-value: 2e-05 | — | — |
PPM009865 | PGS001872 (portability-PLR_697) |
PSS009348| European Ancestry| 19,670 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0199 [0.0059, 0.0338] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009866 | PGS001872 (portability-PLR_697) |
PSS009122| European Ancestry| 4,059 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0123 [-0.0186, 0.0431] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009867 | PGS001872 (portability-PLR_697) |
PSS008676| European Ancestry| 6,565 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0166 [-0.0076, 0.0408] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009868 | PGS001872 (portability-PLR_697) |
PSS008450| Greater Middle Eastern Ancestry| 1,186 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0554 [-0.002, 0.1124] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009869 | PGS001872 (portability-PLR_697) |
PSS008230| South Asian Ancestry| 6,194 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.018 [-0.0069, 0.0429] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009871 | PGS001872 (portability-PLR_697) |
PSS008899| African Ancestry| 3,882 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0332 [0.0017, 0.0647] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009870 | PGS001872 (portability-PLR_697) |
PSS007795| African Ancestry| 2,441 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0157 [-0.0242, 0.0555] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009909 | PGS001878 (portability-PLR_717) |
PSS009355| European Ancestry| 20,000 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0215 [0.0076, 0.0353] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009911 | PGS001878 (portability-PLR_717) |
PSS008683| European Ancestry| 6,660 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0135 [-0.0105, 0.0376] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009912 | PGS001878 (portability-PLR_717) |
PSS008457| Greater Middle Eastern Ancestry| 1,200 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0172 [-0.0399, 0.0742] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009913 | PGS001878 (portability-PLR_717) |
PSS008237| South Asian Ancestry| 6,331 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0191 [-0.0056, 0.0438] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009914 | PGS001878 (portability-PLR_717) |
PSS008016| East Asian Ancestry| 1,810 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): -0.0064 [-0.0527, 0.0399] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009915 | PGS001878 (portability-PLR_717) |
PSS007801| African Ancestry| 2,484 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0191 [-0.0204, 0.0585] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009916 | PGS001878 (portability-PLR_717) |
PSS008905| African Ancestry| 3,924 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0283 [-0.0031, 0.0596] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM009910 | PGS001878 (portability-PLR_717) |
PSS009129| European Ancestry| 4,136 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0281 [-0.0025, 0.0586] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011533 | PGS002084 (portability-ldpred2_697) |
PSS009348| European Ancestry| 19,670 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0184 [0.0044, 0.0324] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011534 | PGS002084 (portability-ldpred2_697) |
PSS009122| European Ancestry| 4,059 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0038 [-0.0271, 0.0346] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011535 | PGS002084 (portability-ldpred2_697) |
PSS008676| European Ancestry| 6,565 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0103 [-0.0139, 0.0345] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011536 | PGS002084 (portability-ldpred2_697) |
PSS008450| Greater Middle Eastern Ancestry| 1,186 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0603 [0.0029, 0.1173] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011537 | PGS002084 (portability-ldpred2_697) |
PSS008230| South Asian Ancestry| 6,194 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0182 [-0.0067, 0.0432] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011538 | PGS002084 (portability-ldpred2_697) |
PSS007795| African Ancestry| 2,441 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0131 [-0.0268, 0.0529] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011539 | PGS002084 (portability-ldpred2_697) |
PSS008899| African Ancestry| 3,882 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Sarcoidosis | — | — | Partial Correlation (partial-r): 0.0187 [-0.0128, 0.0502] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011585 | PGS002091 (portability-ldpred2_717) |
PSS009355| European Ancestry| 20,000 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0222 [0.0084, 0.0361] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011586 | PGS002091 (portability-ldpred2_717) |
PSS009129| European Ancestry| 4,136 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0201 [-0.0104, 0.0506] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011587 | PGS002091 (portability-ldpred2_717) |
PSS008683| European Ancestry| 6,660 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0127 [-0.0113, 0.0368] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011588 | PGS002091 (portability-ldpred2_717) |
PSS008457| Greater Middle Eastern Ancestry| 1,200 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0089 [-0.0482, 0.0659] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011589 | PGS002091 (portability-ldpred2_717) |
PSS008237| South Asian Ancestry| 6,331 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0224 [-0.0023, 0.047] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011590 | PGS002091 (portability-ldpred2_717) |
PSS008016| East Asian Ancestry| 1,810 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): -0.0123 [-0.0586, 0.0341] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011591 | PGS002091 (portability-ldpred2_717) |
PSS007801| African Ancestry| 2,484 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0205 [-0.0191, 0.0599] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM011592 | PGS002091 (portability-ldpred2_717) |
PSS008905| African Ancestry| 3,924 individuals |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Reported Trait: Polymyalgia Rheumatica | — | — | Partial Correlation (partial-r): 0.0283 [-0.003, 0.0596] | sex, age, birth date, deprivation index, 16 PCs | — |
PPM016206 | PGS003354 (SSNS-GRS) |
PSS010057| European Ancestry| 597 individuals |
PGP000407 | Downie ML et al. Pediatr Nephrol (2022) |
Reported Trait: Non-monogenic idiopathic nephrotic syndrome | — | AUROC: 0.638 [0.543, 0.733] | — | — | — |
PPM017318 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: DBP | β: 0.038 (0.093) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017319 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Eosinophils count | β: 0.003 (0.002) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017320 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: FEV1/FVC ratio | β: -0.035 (0.06) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017321 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Fasting insulin | β: 0.156 (0.091) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017322 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HbA1c | β: 0.291 (0.122) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017323 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Hematocrit | β: 0.039 (0.031) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017324 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Hemoglobin | β: 0.014 (0.011) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017325 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-B | β: 1.851 (1.169) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017326 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-IR | β: 0.051 (0.03) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017327 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Heart rate | β: 0.038 (0.106) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017328 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Insomnia | β: 0.015 (0.049) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017329 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: LDL | β: -0.358 (0.336) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017330 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Lymphocyte count | β: 0.002 (0.007) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017331 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Mean arterial pressure | β: 0.011 (0.102) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017333 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: RBC | β: 0.003 (0.003) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017334 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Sleep duration | β: 0.0 (0.013) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017335 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Total cholesterol | β: -0.324 (0.391) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017336 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Triglycerides | β: 0.725 (0.93) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017337 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: WBC | β: 0.006 (0.018) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017338 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Waist hip ratio | β: 0.002 (0.001) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017339 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: FEV1/FVC ratio | β: 0.002 (0.018) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017380 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: DBP in obsese | β: -0.084 (0.148) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017381 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: DBP in non-obsese | β: 0.116 (0.118) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017382 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Fasting insulin in obsese | β: 0.201 (0.161) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017383 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Fasting insulin in non-obsese | β: 0.175 (0.089) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017384 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HbA1c in obsese | β: 0.052 (0.197) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017385 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HbA1c in non-obsese | β: 0.488 (0.151) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017386 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-B in obsese | β: 0.724 (2.105) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017387 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-B in non-obsese | β: 1.664 (1.084) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017388 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-IR in obsese | β: 0.076 (0.057) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017389 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: HOMA-IR in non-obsese | β: 0.062 (0.029) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017390 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Waist hip ratio in obsese | β: 0.002 (0.001) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017391 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Waist hip ratio in non-obsese | β: 0.001 (0.001) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM017332 | PGS003479 (LDPred2_SleepApnea) |
PSS010185| Hispanic or Latin American Ancestry| 1,115 individuals |
PGP000456 | Zhang Y et al. EBioMedicine (2022) |
Reported Trait: Pulse pressure | β: -0.073 (0.104) | — | — | Age, sex, center, 5 genetic PCs, Hispanic/Latino background, BMI | — |
PPM018710 | PGS003857 (GRS18_BMIunadj) |
PSS011076| Multi-ancestry (including European)| 40,193 individuals |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Reported Trait: BMI adjusted obstructive sleep apnea | β: 0.014 (0.017) | AUROC: 0.77 [0.75, 0.78] | — | BMI, age, sex, genetic batch, PCs 1-10 | — |
PPM018709 | PGS003857 (GRS18_BMIunadj) |
PSS011076| Multi-ancestry (including European)| 40,193 individuals |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Reported Trait: BMI unadjusted obstructive sleep apnea | β: 0.082 (0.016) | AUROC: 0.66 [0.64, 0.67] | — | age, sex, genetic batch, PCs 1-10 | — |
PPM018711 | PGS003858 (GRS6_BMIadj) |
PSS011076| Multi-ancestry (including European)| 40,193 individuals |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Reported Trait: BMI unadjusted obstructive sleep apnea | β: 0.048 (0.015) | AUROC: 0.62 [0.61, 0.64] | — | age, sex, genetic batch, PCs 1-10 | — |
PPM018712 | PGS003858 (GRS6_BMIadj) |
PSS011076| Multi-ancestry (including European)| 40,193 individuals |
PGP000496 | Sofer T et al. EBioMedicine (2023) |
Reported Trait: BMI adjusted obstructive sleep apnea | β: 0.066 (0.017) | AUROC: 0.77 [0.76, 0.79] | — | BMI, age, sex, genetic batch, PCs 1-10 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS008905 | — | — | 3,924 individuals | — | African unspecified | Nigeria (West Africa) | UKB | — |
PSS004551 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004552 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004553 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004554 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS008016 | — | — | 1,810 individuals | — | East Asian | China (East Asia) | UKB | — |
PSS000905 | Intravenous ajmaline was administered at consecutive boluses of 10 mg/min. A 10-s ECG was recorded ∼1 min after each bolus using a GE Healthcare electrocardiograph. The test was stopped when the target dose of 1 mg/kg rounded up to the next 10 mg was reached, if ventricular arrhythmia occurred, or at the manifestation of a Type I BrS pattern, defined as an ST elevation >2 mm with a coved morphology in any lead among V1–V2 in the 2nd to 4th intercostal spaces.15 | — | 1,185 individuals | — | European | — | Amsterdam | — |
PSS010057 | — | — | 597 individuals | — | European | — | NR | BRIDGE |
PSS004437 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004438 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004439 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004440 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004441 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS008676 | — | — | 6,565 individuals | — | European | Italy (South Europe) | UKB | — |
PSS004322 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004323 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004324 | — | — | [
|
— | South Asian | — | UKB | — |
PSS000312 | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | Median = 8.0 years | [ ,
32.0 % Male samples |
— | European | — | PHB | — |
PSS000313 | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | Median = 7.0 years | [ ,
32.0 % Male samples |
— | European | — | PHB | — |
PSS004325 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004706 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004707 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004708 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004709 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004710 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS007795 | — | — | 2,441 individuals | — | African American or Afro-Caribbean | Carribean | UKB | — |
PSS000321 | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | Median = 16.0 years | [ ,
43.0 % Male samples |
— | European, African unspecified, Asian unspecified, NR | Primarily European, African and Asian ancestry | eMERGE | — |
PSS007801 | — | — | 2,484 individuals | — | African American or Afro-Caribbean | Carribean | UKB | — |
PSS010185 | — | — | 1,115 individuals, 41.1 % Male samples |
Mean = 46.18 years | Hispanic or Latin American | — | HCHS, SOL | — |
PSS008450 | — | — | 1,186 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | Iran (Middle East) | UKB | — |
PSS009348 | — | — | 19,670 individuals | — | European | UK (+ Ireland) | UKB | — |
PSS008457 | — | — | 1,200 individuals | — | Greater Middle Eastern (Middle Eastern, North African or Persian) | Iran (Middle East) | UKB | — |
PSS009355 | — | — | 20,000 individuals | — | European | UK (+ Ireland) | UKB | — |
PSS000490 | Cases included physician-confirmed psoriatic arthritis (PsA). Controls inclded individuals with psoriasis with no history of joint symptoms (psoriasis only - PsO). | — | [
|
— | NR | — | NR | — |
PSS004751 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004752 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004753 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004754 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004755 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS007671 | An atrial tachyarrhythmia characterised by rapid (usually faster than 300 bpm), irregular and uncoordinated atrial impulse generation, usually manifesting on ECG with indistinct P-waves and an irregularly irregular ventricular response. | — | [
|
— | European | British | UKB | — |
PSS007672 | Disorder of the atrioventricular conduction system in which there is failure of all atrial impulses to propagate to the ventricle | — | [
|
— | European | British | UKB | — |
PSS007675 | Disorder of the atrioventricular conduction system in which there is failure of all atrial impulses to propagate to the ventricle or Any of a number of possible arrhythmias originating from at or above the level of bundle of His in which the heart beats slower than the age-dependent lower limits of normal. | — | [
|
— | European | British | UKB | — |
PSS007676 | Electrocardiogram PQ interval | — | 11,942 individuals | — | European | British | UKB | — |
PSS007677 | Electrocardiogram P-wave duration | — | 11,566 individuals | — | European | British | UKB | — |
PSS007678 | Electrocardiogram QRS duration | — | 11,877 individuals | — | European | British | UKB | — |
PSS007679 | Electrocardiogram QT interval | — | 11,893 individuals | — | European | British | UKB | — |
PSS007680 | associated with episodes of atrial tachycardia | — | [
|
— | European | British | UKB | — |
PSS007673 | Pathogenicity of rare variants in SCN5A identified in included BrS cases was centrally assessed using the American College of Medical Genetics and Genomics and Association of Molecular Pathology (ACMG/AMP) guidelines, using an adapted version of CardioClassifier incorporating a quantitative approach based on case-control analyses, as performed previously in hypertrophic cardiomyopathy genes, as well as a curated compendium of functional data. | — | [
|
— | European | Dutch, Belgian, German, British, Turkish, Italian, Spanish, Danish, French, Irish | NR | These samples overlap with the cases used in the score development |
PSS007674 | A type 1 Brugada Syndrome ECG was defined as a coved type ST elevation at baseline (spontaneous) or after a drug challenge test, in one or more leads in the right precordial leads V1 and/or V2 in the standard position (4th intercostal space) or in high positions (2nd or 3rd intercostal spaces). | — | [
|
— | European | Dutch, Belgian, German, British, Turkish, Italian, Spanish, Danish, French, Irish | NR | These samples overlap with the cases used in the score development |
PSS009122 | — | — | 4,059 individuals | — | European | Poland (NE Europe) | UKB | — |
PSS008230 | — | — | 6,194 individuals | — | South Asian | India (South Asia) | UKB | — |
PSS011076 | — | — | 2,023 individuals, 37.4 % Male samples |
Mean = 53.16 years Sd = 16.23 years |
African unspecified | — | MGBB | — |
PSS009129 | — | — | 4,136 individuals | — | European | Poland (NE Europe) | UKB | — |
PSS011076 | — | — | 34,764 individuals, 46.7 % Male samples |
Mean = 60.62 years Sd = 16.83 years |
European | — | MGBB | — |
PSS011076 | — | — | 1,182 individuals, 31.3 % Male samples |
Mean = 52.29 years Sd = 16.56 years |
Hispanic or Latin American | — | MGBB | — |
PSS011076 | — | — | 1,292 individuals, 46.8 % Male samples |
Mean = 52.08 years Sd = 18.42 years |
Not reported | — | MGBB | — |
PSS008237 | — | — | 6,331 individuals | — | South Asian | India (South Asia) | UKB | — |
PSS011076 | — | — | 932 individuals, 41.8 % Male samples |
Mean = 47.0 years Sd = 15.67 years |
Asian unspecified | — | MGBB | — |
PSS008683 | — | — | 6,660 individuals | — | European | Italy (South Europe) | UKB | — |
PSS008899 | — | — | 3,882 individuals | — | African unspecified | Nigeria (West Africa) | UKB | — |